Table 2.
Clinicopathological factors | Discription | NO. of cases | VDR | P | ||
---|---|---|---|---|---|---|
|
||||||
(+) | (-) | PR (%) | ||||
Age (years) | 0.684 | |||||
< 55 | 40 | 24 | 16 | 60.00 | ||
≥ 55 | 52 | 29 | 23 | 55.77 | ||
Gender | 0.557 | |||||
Male | 63 | 35 | 28 | 55.56 | ||
Female | 29 | 18 | 11 | 62.07 | ||
Tumor location | 0.757 | |||||
Cardia | 13 | 8 | 5 | 61.54 | ||
Fundic, body, antral | 79 | 45 | 34 | 56.96 | ||
Tumor size (cm) | 0.009* | |||||
< 5 | 61 | 41 | 20 | 67.21 | ||
≥ 5 | 31 | 12 | 19 | 38.71 | ||
Differentiation degree | 0.016* | |||||
High | 40 | 28 | 12 | 70.00 | ||
Middle | 20 | 13 | 7 | 65.00 | ||
Low | 32 | 12 | 20 | 37.50 | ||
Pathological type | 0.606 | |||||
Pathological type | 37 | 23 | 14 | 62.16 | ||
Polypoid adenocarcinoma | 23 | 14 | 9 | 60.87 | ||
Mucinous adenocarcinoma | 24 | 13 | 11 | 54.17 | ||
Signet-ring cell carcinoma | 8 | 3 | 5 | 37.50 | ||
Lymphnode metastasis | 0.136 | |||||
Yes | 58 | 30 | 28 | 51.72 | ||
No | 34 | 23 | 11 | 67.65 | ||
TNM stage | 0.635 | |||||
I+II | 38 | 23 | 15 | 60.53 | ||
III+IV | 54 | 30 | 24 | 55.56 |
Indicates statistical significance.